Diazepam
Overview
Diazepam is a benzodiazepine that enhances the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA-A receptor, producing sedative and anxiolytic effects. It is commonly used to treat anxiety, muscle spasms, and seizures.
API suppliers (7)
Suppliers of Diazepam evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 5 of 7 suppliers.
3 of 7 hold a GMP certificate on record in the EU or UK registers
- R L Fine Chem Pvt. Ltd.India1 active DMF
- NAVINTA LLCUnited States1 active DMF
- CENTAUR PHARMACEUTICALS PRIVATE LTD1 active DMF GMP on record
- FIS FABBRICA ITALIANA SINTETICI SPAItaly1 active DMF GMP on record
- CAMBREX PROFARMACO MILANO SRLItaly1 active DMF GMP on record
- DELMAR CHEMICALS INCCanada
- Gedeon Richter Usa
Patent & exclusivity (US)
Per the FDA Orange Book (44 approved US products), the latest listed US patent on Diazepam expires 10 Jun 2042 and exclusivity 15 Apr 2028. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one
- Canonical SMILES
- CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
- InChIKey
- AAOVKJBEBIDNHE-UHFFFAOYSA-N
Therapeutic areas
Do you supply Diazepam? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.